Guangzhou Guanggang Gases & Energy Co.,Ltd. (SHA:688548)
China · Delayed Price · Currency is CNY 20.72
+0.50 (2.47%)
At close: Feb 6, 2026
SHA:688548 Revenue
In the year 2025, Guangzhou Guanggang Gases & Energy had annual revenue of 2.42B CNY with 15.26% growth. Guangzhou Guanggang Gases & Energy had revenue of 703.48M in the quarter ending December 31, 2025, with 16.28% growth.
Revenue
2.42B
Revenue Growth
+15.26%
P/S Ratio
11.27
Revenue / Employee
2.21M
Employees
1,114
Market Cap
27.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.42B | 321.01M | 15.26% |
| Dec 31, 2024 | 2.10B | 268.05M | 14.60% |
| Dec 31, 2023 | 1.84B | 295.66M | 19.20% |
| Dec 31, 2022 | 1.54B | 361.85M | 30.72% |
| Dec 31, 2021 | 1.18B | 310.70M | 35.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Construction Group | 244.28B |
| Jointown Pharmaceutical Group | 157.71B |
| AIMA Technology Group CO., LTD | 25.24B |
| Chongqing Brewery | 14.64B |
| Jinneng Holding Shanxi Coal Industry Co.,ltd. | 13.12B |
| LAPLACE Renewable Energy Technology | 5.75B |
| Kangmei Pharmaceutical | 5.28B |
| Delijia Transmission Technology (Jiangsu) | 4.44B |